Notice of Interim Results
Source: RNS
Spire Healthcare Group plc
('Spire Healthcare', 'the Company' or 'the Group')
Notice of Interim Results
15 August 2024
Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group in the United Kingdom, will announce its interim results for the six months ended 30 June 2024 on Thursday, 12 September 2024.
A presentation for sell-side analysts and institutional investors will be held on the day of the interim results announcement at 9.00am (BST) at the offices of Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ. Refreshments will be available from 8.30am (BST). If you wish to attend the presentation, please contact Instinctif Partners at spire@instinctif.com.
Following the presentation, there will be a moderated Q&A session.
For those who cannot attend in person, the presentation will also be accessible via live Zoom webcast.
Click the following link to register in advance for the Zoom webcast and to receive access details:
https://spirehealthcare.zoom.us/webinar/register/WN_lnWbJHGcQs2BHYE8b9lcTA
A recording of the webcast will be made available from 1.00pm (BST) on 12 September on the Spire Healthcare website, https://www.investors.spirehealthcare.com
- Ends -
For further information please contact:
|
Spire Healthcare Angus Prentice - Director of Investor Relations
|
+44 (0)7974 982 512 |
|
Instinctif Partners Julian Walker Guy Scarborough |
+44 (0)7825 189 696 +44 (0)7917 178 920 |
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare is a leading independent healthcare group in the United Kingdom, running 39 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.
Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1 million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand.
Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good', 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.
Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
